drugset / Trial / NCT06194955

The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function

NCT06194955

RandomizedCrossoverSingle-blindBasic science

Summary

This project will characterize the physiological effect of the hormones, GIP-, GLP-1- and GLP-2 infusions in a group of individuals that are carriers of GIP-, GLP-1- and GLP-2 receptor gene variants, respectively.

Timeline

Start
2023-01-04
Primary completion
2025-12-10
Completion
2026-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator GIP(1-42) Unknown Other
Comparator GLP-1 Peptide Other
Comparator GLUCAGON-LIKE PEPTIDE II Peptide Other

Indications